Anti-intercellular adhesion molecule 1 monomaintenance therapy induced long-term liver allograft survival without chronic rejection.
Han DK, Hong SK, Yun IH, Yan JJ, Park J, Kim SW, Seok SH, Kim H, Ji G, Choi Y, Lee KW, Suh KS, Yang J, Yi NJ.
Han DK, et al. Among authors: suh ks.
Am J Transplant. 2024 Mar 30:S1600-6135(24)00247-8. doi: 10.1016/j.ajt.2024.03.037. Online ahead of print.
Am J Transplant. 2024.
PMID: 38561059
Despite its promising results with short-term therapy, overcoming the challenge of chronic rejection remains important. Thus, we aimed to investigate the outcomes of long-term MD3 therapy with monthly MD3 monomaintenance in nonhuman primate LT models. ...
Despite its promising results with short-term therapy, overcoming the challenge of chronic rejection remains important. Thus, we aime …